Reductions in alcohol intake were noted in high and low consumers; no significant difference was seen in percentage reductions for men and women.

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

Patients using SGLT2i preoperatively have a slightly increased risk for postoperative euglycemic ketoacidosis but a lower risk for AKI and mortality.

Maternal obesity and hypothyroxinemia were independently and synergistically associated with increased risk for large for gestational age.

Oocyte retrieval outcomes were similar between patients with a BMI of at least 45 kg/m2 and patients with BMI of 40 to 44.9 kg/m2.

The FDA has approved Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic PPGL.